本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pacific Biosciences of Californi

1.48
-0.0200-1.33%
盘后1.47-0.0100-0.68%19:29 EDT
成交量:594.84万
成交额:862.87万
市值:4.44亿
市盈率:-0.63
高:1.50
开:1.50
低:1.41
收:1.50
数据加载中...
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/07

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report
2020/08/03

重要事件披露

8-K - Current report
2020/07/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/10

重要事件披露

8-K - Current report
2020/05/28

重要事件披露

8-K - Current report
2020/05/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/03/06

重要事件披露

8-K - Current report